$NBIO news out this morning: Company Completes Third Cohort

$NBIO news out this morning: Company Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancer https://www.otcmarkets.com/stock/NBIO/news/Na...?id=360180